CORD-19:c654596857bce9cdd64ffc51842048643107348c / 270110-270357 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T2289","span":{"begin":0,"end":247},"obj":"Sentence"},{"id":"T80753","span":{"begin":0,"end":247},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In young children there is a prevalence of serogroup B meningococcal disease which can be explained by the immaturity of the immune system and by the fact the group B capsule synthesis is known to inhibit alternative complement pathway activation."}

{"project":"Epistemic_Statements","denotations":[{"id":"T353","span":{"begin":0,"end":247},"obj":"Epistemic_statement"}],"text":"In young children there is a prevalence of serogroup B meningococcal disease which can be explained by the immaturity of the immune system and by the fact the group B capsule synthesis is known to inhibit alternative complement pathway activation."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T210","span":{"begin":0,"end":247},"obj":"Sentence"}],"text":"In young children there is a prevalence of serogroup B meningococcal disease which can be explained by the immaturity of the immune system and by the fact the group B capsule synthesis is known to inhibit alternative complement pathway activation."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T319","span":{"begin":125,"end":138},"obj":"Body_part"},{"id":"T320","span":{"begin":167,"end":174},"obj":"Body_part"}],"attributes":[{"id":"A319","pred":"uberon_id","subj":"T319","obj":"http://purl.obolibrary.org/obo/UBERON_0002405"},{"id":"A320","pred":"uberon_id","subj":"T320","obj":"http://purl.obolibrary.org/obo/UBERON_0003893"}],"text":"In young children there is a prevalence of serogroup B meningococcal disease which can be explained by the immaturity of the immune system and by the fact the group B capsule synthesis is known to inhibit alternative complement pathway activation."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1299","span":{"begin":55,"end":76},"obj":"Disease"},{"id":"T96166","span":{"begin":55,"end":76},"obj":"Disease"}],"attributes":[{"id":"A1299","pred":"mondo_id","subj":"T1299","obj":"http://purl.obolibrary.org/obo/MONDO_0005373"},{"id":"A99942","pred":"mondo_id","subj":"T96166","obj":"http://purl.obolibrary.org/obo/MONDO_0005373"}],"text":"In young children there is a prevalence of serogroup B meningococcal disease which can be explained by the immaturity of the immune system and by the fact the group B capsule synthesis is known to inhibit alternative complement pathway activation."}